NO20042810L - Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav - Google Patents

Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav

Info

Publication number
NO20042810L
NO20042810L NO20042810A NO20042810A NO20042810L NO 20042810 L NO20042810 L NO 20042810L NO 20042810 A NO20042810 A NO 20042810A NO 20042810 A NO20042810 A NO 20042810A NO 20042810 L NO20042810 L NO 20042810L
Authority
NO
Norway
Prior art keywords
venflaxine
processes
preparation
hydrochloride monohydrate
monohydrate
Prior art date
Application number
NO20042810A
Other languages
English (en)
Inventor
Jun Han
Yong Jai Lee
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20042810L publication Critical patent/NO20042810L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20042810A 2001-12-05 2004-07-02 Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav NO20042810L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33582301P 2001-12-05 2001-12-05
PCT/US2002/038581 WO2003050076A1 (en) 2001-12-05 2002-12-03 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
NO20042810L true NO20042810L (no) 2004-07-02

Family

ID=23313363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042810A NO20042810L (no) 2001-12-05 2004-07-02 Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav

Country Status (20)

Country Link
US (2) US20030114536A1 (no)
EP (1) EP1451146A1 (no)
JP (1) JP2005511737A (no)
KR (1) KR20050044711A (no)
CN (1) CN1599715A (no)
AR (1) AR037636A1 (no)
AU (1) AU2002366574A1 (no)
BR (1) BR0214696A (no)
CA (1) CA2467614A1 (no)
CO (1) CO5580817A2 (no)
EC (1) ECSP045134A (no)
HU (1) HUP0402553A2 (no)
MX (1) MXPA04005307A (no)
NO (1) NO20042810L (no)
PL (1) PL370559A1 (no)
RU (1) RU2004120273A (no)
TW (1) TW200300669A (no)
UA (1) UA77234C2 (no)
WO (1) WO2003050076A1 (no)
ZA (1) ZA200405245B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002348266A1 (en) * 2001-12-05 2003-06-23 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
EP1773321A2 (en) * 2004-07-22 2007-04-18 Wyeth Method for treating nervous system disorders and conditions
MX2007000851A (es) * 2004-07-22 2007-03-26 Wyeth Corp Procedimiento para el tratamiento de trastornos y dolencias del sistema nervioso.
CN101410106A (zh) * 2004-07-22 2009-04-15 惠氏公司 治疗神经系统障碍和病症的方法
CA2625832A1 (en) * 2005-10-19 2007-04-26 Vinod Kumar Kansal Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
PL2032521T3 (pl) 2006-06-27 2010-05-31 Sandoz Ag Nowy sposób wytwarzania soli
MX385316B (es) 2007-05-01 2025-03-18 Concert Pharmaceuticals Inc Compuestos de morfinano.
US20120083487A1 (en) * 2008-10-30 2012-04-05 Amanda Thomas Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
CA3208241A1 (en) * 2015-08-31 2017-03-09 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1738753E (pt) * 1993-06-28 2008-06-19 Wyeth Corp Novos tratamentos utilizando derivados de fenetilamina
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
DE01988460T1 (de) * 2000-10-19 2004-04-22 Teva Pharmaceutical Industries Ltd. Kristalline venlafaxinbase und neue venlafaxin-hydrochlorid-modifikationen sowie verfahren zu deren herstellung
AU1234002A (en) * 2000-10-31 2002-05-15 Ciba Sc Holding Ag Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) * 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
CN1599715A (zh) 2005-03-23
ECSP045134A (es) 2004-07-23
TW200300669A (en) 2003-06-16
UA77234C2 (en) 2006-11-15
ZA200405245B (en) 2007-01-31
CA2467614A1 (en) 2003-06-19
US20030114536A1 (en) 2003-06-19
EP1451146A1 (en) 2004-09-01
RU2004120273A (ru) 2005-03-27
MXPA04005307A (es) 2004-09-13
PL370559A1 (en) 2005-05-30
CO5580817A2 (es) 2005-11-30
AR037636A1 (es) 2004-11-17
JP2005511737A (ja) 2005-04-28
BR0214696A (pt) 2004-11-03
HUP0402553A2 (hu) 2005-03-29
WO2003050076A1 (en) 2003-06-19
US20050272822A1 (en) 2005-12-08
KR20050044711A (ko) 2005-05-12
AU2002366574A1 (en) 2003-06-23

Similar Documents

Publication Publication Date Title
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
IL162253A0 (en) Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
NO20033565D0 (no) Acylerte indanylaminer og deres anvendelse som farmasöytiske midler
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20035634L (no) Diamin-derivater
NO20035366D0 (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO2011021I1 (no) Apixaban og farmasøytiske akseptable salter derav
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DE60234125D1 (de) E inhibitoren
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DE60235767D1 (de) Sublimationsmuster-giessverfahren
NO20035315D0 (no) Farmasöytiske kombinasjoner
BR0207810A (pt) inibidores de deformilase de peptìdeo
NO20021569L (no) Rensete kitiner og fremgangsmåte for deres fremstilling
DK1572950T3 (da) Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
ZA200405245B (en) Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
ATE523892T1 (de) Klemmhilfe
EP1499310A4 (en) MONOCITRATE MONOHYDRATE OF CARVEDILOL
NO20033324L (no) Anti-stressmiddel
DE50208514D1 (de) Spannvorrichtung
NO20033965L (no) Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application